Travere Therapeutics (TVTX) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free TVTX Stock Alerts $6.76 +0.60 (+9.74%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Travere Therapeutics Short Interest DataCurrent Short Interest13,440,000 sharesPrevious Short Interest12,810,000 sharesChange Vs. Previous Month+4.92%Dollar Volume Sold Short$91.39 millionShort Interest Ratio11.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares76,130,000 sharesPercentage of Shares Shorted17.65%Today's Trading Volume1,323,413 sharesAverage Trading Volume1,100,954 sharesToday's Volume Vs. Average120% Short Selling Travere Therapeutics ? Sign up to receive the latest short interest report for Travere Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTVTX Short Interest Over TimeTVTX Days to Cover Over TimeTVTX Percentage of Float Shorted Over Time Ad Porter & CompanyObama’s Forever Term [exposed]Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here Travere Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202413,440,000 shares $91.39 million +4.9%N/A11 $6.80 4/30/202412,810,000 shares $70.84 million +8.6%N/A10.3 $5.53 4/15/202411,800,000 shares $74.58 million +11.3%N/A9.9 $6.32 3/31/202410,600,000 shares $81.73 million +5.3%N/A8.8 $7.71 3/15/202410,070,000 shares $75.42 million -1.9%N/A8.2 $7.49 2/29/202410,260,000 shares $77.57 million +5.1%N/A7.5 $7.56 Get the Latest News and Ratings for TVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Travere Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20249,760,000 shares $85.30 million -1.7%N/A6.7 $8.74 1/31/20249,930,000 shares $88.67 million +2.3%N/A6.3 $8.93 1/15/20249,710,000 shares $92.54 million -2.1%N/A5.8 $9.53 12/31/20239,920,000 shares $89.18 million +2.9%N/A5.9 $8.99 12/15/20239,640,000 shares $83.48 million -3.1%N/A5.8 $8.66 11/30/20239,950,000 shares $62.49 million -6.7%N/A5 $6.28 11/15/202310,660,000 shares $65.77 million +21.0%N/A5.9 $6.17 10/31/20238,810,000 shares $57.09 million +0.5%N/A5.2 $6.48 10/15/20238,770,000 shares $62.27 million +4.2%N/A5.6 $7.10 9/30/20238,420,000 shares $75.27 million -6.9%N/A5.8 $8.94 9/15/20239,040,000 shares $123.76 million +5.7%N/A6.7 $13.69 8/31/20238,550,000 shares $122.09 million +5.6%N/A8.3 $14.28 8/15/20238,100,000 shares $123.12 million +0.4%N/A7.6 $15.20 7/31/20238,070,000 shares $138.72 million -2.7%N/A7.3 $17.19 7/15/20238,290,000 shares $126.92 million -2.5%N/A6.5 $15.31 6/30/20238,500,000 shares $130.56 million +11.0%N/A6.3 $15.36 6/15/20237,660,000 shares $131.75 million +4.9%N/A5.4 $17.20 5/31/20237,300,000 shares $130.60 million -3.2%N/A5.4 $17.89 5/15/20237,540,000 shares $123.20 million -4.1%N/A4.7 $16.34 4/30/20237,860,000 shares $169.54 million -3.7%N/A4.7 $21.57 4/15/20238,160,000 shares $165.81 million -4.5%N/A5.6 $20.32 3/31/20238,540,000 shares $192.06 million +14.8%N/A5.7 $22.49 3/15/20237,440,000 shares $158.25 million -1.6%N/A5.4 $21.27 2/28/20237,560,000 shares $167.53 million +9.9%N/A5.7 $22.16 2/15/20236,880,000 shares $138.43 million -7.7%N/A5.8 $20.12 1/31/20237,450,000 shares $166.88 million -0.9%N/A8.8 $22.40 1/15/20237,520,000 shares $152.81 million -10.3%N/A9.1 $20.32 12/30/20228,380,000 shares $176.23 million +3.1%N/A10 $21.03 12/15/20228,130,000 shares $150.41 million -1.2%N/A9.7 $18.50 11/30/20228,230,000 shares $165.67 million +5.9%N/A10.6 $20.13 11/15/20227,770,000 shares $167.13 million -1.2%N/A10.4 $21.51 10/31/20227,860,000 shares $170.40 million +23.0%13.0%10.9 $21.68 10/15/20226,390,000 shares $132.15 million -6.2%10.6%8.4 $20.68 9/30/20226,810,000 shares $167.80 million +3.0%11.3%10.3 $24.64Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now 9/15/20226,610,000 shares $179.79 million -0.5%11.0%9.9 $27.20 8/31/20226,640,000 shares $177.69 million -10.2%11.1%9 $26.76 8/15/20227,390,000 shares $211.28 million +7.9%12.3%9.7 $28.59 7/31/20226,850,000 shares $161.25 million +2.4%11.5%7.9 $23.54 7/15/20226,690,000 shares $163.97 million -5.0%11.2%8.4 $24.51 6/30/20227,040,000 shares $170.58 million +6.2%11.8%8.6 $24.23 6/15/20226,630,000 shares $160.18 million -10.4%11.1%8 $24.16 5/31/20227,400,000 shares $172.49 million -12.6%12.4%8.9 $23.31 5/15/20228,470,000 shares $187.86 million +3.7%14.2%9.7 $22.18 4/30/20228,170,000 shares $205.31 million +14.1%13.8%10.5 $25.13 4/15/20227,160,000 shares $212.22 million +0.7%12.1%9.3 $29.64 3/31/20227,110,000 shares $183.22 million -6.5%12.0%9.8 $25.77 3/15/20227,600,000 shares $181.72 million +29.3%12.8%11.5 $23.91 2/28/20225,880,000 shares $160.29 million -1.7%10.0%9.1 $27.26 2/15/20225,980,000 shares $171.39 million +11.4%10.5%11 $28.66 1/31/20225,370,000 shares $147.68 million +8.5%9.3%10.6 $27.50 1/15/20224,950,000 shares $136.32 million -15.5%8.5%9.3 $27.54 12/31/20215,860,000 shares $181.89 million -6.4%N/A0 $31.04 12/15/20216,260,000 shares $182.48 million +0.6%10.8%11.6 $29.15 11/30/20216,220,000 shares $177.58 million +3.0%10.7%10.5 $28.55 11/15/20216,040,000 shares $177.39 million -1.2%10.4%9.7 $29.37 10/29/20216,110,000 shares $176.03 million +0.5%10.1%5 $28.81 10/15/20216,080,000 shares $148.96 million -6.9%10.2%5.1 $24.50 9/30/20216,530,000 shares $158.35 million -5.6%10.9%5.4 $24.25 9/15/20216,920,000 shares $162.83 million -3.1%11.5%5.4 $23.53 8/31/20217,140,000 shares $155.87 million +6.7%11.9%5.5 $21.83 8/13/20216,690,000 shares $103.36 million -1.6%11.2%4.9 $15.45 7/30/20216,800,000 shares $93.50 million +2.6%11.4%8.3 $13.75 7/15/20216,630,000 shares $90.83 million -1.5%11.1%8 $13.70 6/30/20216,730,000 shares $98.19 million +23.0%11.3%8.3 $14.59 6/15/20215,470,000 shares $81.67 million +19.4%9.2%7.5 $14.93 5/28/20214,580,000 shares $69.48 million -0.4%7.7%7 $15.17 5/14/20214,600,000 shares $86.94 million -3.2%7.7%8.7 $18.90 4/30/20214,750,000 shares $117.85 million -1.5%8.0%8.2 $24.81 4/15/20214,820,000 shares $122.48 million -6.4%8.1%7.7 $25.41 3/31/20215,150,000 shares $125.25 million +20.9%8.6%8.3 $24.32 3/15/20214,260,000 shares $122.43 million +3.2%7.2%6.9 $28.74 2/26/20214,130,000 shares $122.66 million -1.7%7.0%6.9 $29.70 2/12/20214,200,000 shares $116.72 million -0.7%7.4%7.3 $27.79 1/29/20214,230,000 shares $109.09 million -2.8%8.4%8.9 $25.79 1/15/20214,350,000 shares $126.67 million No Change8.6%11.1 $29.12 TVTX Short Interest - Frequently Asked Questions What is Travere Therapeutics' current short interest? Short interest is the volume of Travere Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 13,440,000 shares of TVTX short. Learn More on Travere Therapeutics' current short interest. What is a good short interest ratio for Travere Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TVTX shares currently have a short interest ratio of 11.0. Learn More on Travere Therapeutics's short interest ratio. Is Travere Therapeutics' short interest increasing or decreasing? Travere Therapeutics saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 13,440,000 shares, an increase of 4.9% from the previous total of 12,810,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Travere Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Travere Therapeutics: Larimar Therapeutics, Inc. (6.13%), Astria Therapeutics, Inc. (9.62%), IGM Biosciences, Inc. (24.78%), KalVista Pharmaceuticals, Inc. (13.65%), Entrada Therapeutics, Inc. (9.08%), Heron Therapeutics, Inc. (20.09%), Applied Therapeutics, Inc. (4.00%), Olema Pharmaceuticals, Inc. (15.27%), Oculis Holding AG (0.23%), Fulcrum Therapeutics, Inc. (4.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Travere Therapeutics stock? Short selling TVTX is an investing strategy that aims to generate trading profit from Travere Therapeutics as its price is falling. TVTX shares are trading up $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Travere Therapeutics? A short squeeze for Travere Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TVTX, which in turn drives the price of the stock up even further. How often is Travere Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TVTX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Larimar Therapeutics Short Interest Data Astria Therapeutics Short Interest Data IGM Biosciences Short Interest Data KalVista Pharmaceuticals Short Interest Data Entrada Therapeutics Short Interest Data Heron Therapeutics Short Interest Data Applied Therapeutics Short Interest Data Olema Pharmaceuticals Short Interest Data Oculis Short Interest Data Fulcrum Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TVTX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersA once-in-a-century investment opportunityStansberry ResearchThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Travere Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.